Document Detail


Stroke prevention and statin treatment.
MedLine Citation:
PMID:  16833043     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Randomized trials with statins have shown a modest but significant absolute reduction in the incidence of stroke in patients with a previous myocardial infarction. The reasons for the positive statin effect on stroke endpoint are unclear, because a link between serum cholesterol level and stroke never has been established. However, positive results of statin trials were mainly obtained in patients with an average or a low serum cholesterol level. Statins have a good overall safety profile. Statins reduced stroke incidence in high-risk (mainly coronary heart disease, diabetics, and hypertensives) population even with a normal baseline blood cholesterol level. In patients with prior strokes, statins reduce the incidence of coronary events, but it is not yet proven if drugs of this class actually reduce the incidence of recurrent strokes in terms of secondary prevention.
Authors:
Lucilla Parnetti; Valeria Caso; Alessia Lanari; Emanuele Saggese; Michela Sebastianelli; Seyed Khosrow Tayebati; Francesco Amenta
Related Documents :
8651103 - Direct measurement of serum low-density lipoprotein cholesterol in patients with acute ...
20854963 - Kif6 polymorphism as a predictor of risk of coronary events and of clinical event reduc...
21098783 - Assessment of left ventricular function in older medicare beneficiaries with newly diag...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  28     ISSN:  1064-1963     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:    2006 Apr-May
Date Detail:
Created Date:  2006-07-12     Completed Date:  2006-07-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  335-44     Citation Subset:  IM    
Affiliation:
Department of Neuroscience, University of Perugia, Perugia, Italy. parnetti@unipg.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hyperlipidemias / complications,  drug therapy
Incidence
Stroke / epidemiology,  etiology,  prevention & control*
Survival Rate
Treatment Outcome
Chemical
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Problems related to short-term antihypertensive therapy in acute ischemic stroke.
Next Document:  New developments on drug treatment rehabilitation.